News

Eric Schmidt-backed nonprofit FutureHouse is previewing an AI tool for 'data-driven' biology discovery, called Finch.
Anthropic is launching an AI for Science program to support researchers working on 'high-impact' scientific projects.
Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development INDIANAPOLIS and EHIME, Japan, May 5, 2025 /PRNewswire/ -- ...
Matica Biotechnology, a specialized contract development and manufacturing organization (CDMO) for cell and gene therapies (CGT), has entered into a strategic partnership with the National Center for ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
I know firsthand how a misaligned gene vector can lead to ineffective therapies, just as misallocated business resources result in inefficiencies and missed opportunities. In both biotech and ...
Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Purple Biotech (PPBT) announced the publication of an independent study titled “IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategies ...
EQS Dissemination of Financial Reports: Marinomed Biotech AG / Release of Financial Reports Marinomed Biotech AG: Release of a Financial report 16.04.2025 / 07:45 CET/CEST Announcement according ...